The Rosen Law Firm is investigating potential securities claims against Gildan Activewear Inc. following allegations of materially misleading business disclosures. On June 16, 2026, a short report by Jehoshaphat Research questioned the company's organic growth and sales practices, alleging that negative organic growth was masked through financial engineering. The stock declined 18.7% on the news. Investors who purchased Gildan securities may be eligible for compensation.

Rosen Law Firm is investigating potential securities claims against Gildan Activewear Inc. following a short seller report by Jehoshaphat Research that alleged the company's organic growth has been negative for years despite appearing to show revenue growth through financial engineering. Gildan's stock fell 18.7% on June 16, 2026, following the report's release. The firm is preparing a class action lawsuit to recover investor losses.

Law firm Girard Sharp LLP is investigating potential securities claims on behalf of former HanesBrands investors who received Gildan shares in the December 2025 acquisition. Gildan's stock price has declined significantly since the merger closed, prompting the investigation into potential securities violations.

Girard Sharp LLP is investigating potential securities claims on behalf of former HanesBrands investors who received Gildan shares in the December 2025 acquisition. Gildan's stock price has declined significantly since the merger closed, prompting the law firm to seek affected investors for a class action lawsuit.

Girard Sharp LLP is investigating potential securities claims on behalf of former HanesBrands investors who received Gildan shares in the December 2025 acquisition. Gildan's stock price has declined significantly since the merger closed, prompting the law firm to encourage affected investors to contact them for a free consultation.

Gildan Activewear's stock dropped 11% after short-seller Jehoshaphat Research published a 60-page critical report accusing the company of channel stuffing, tax malfeasance, and accounting irregularities. The report alleged that Gildan inflated growth numbers by selling excess inventory into distribution channels beyond current demand. Gildan responded with a brief statement defending its disclosure practices.

Law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into Gildan Activewear Inc. following a Jehoshaphat Research report alleging channel stuffing, revenue manipulation, and off-balance-sheet financial engineering. The allegations caused Gildan's stock to fall 18.8% on June 16, 2026. The firm is seeking investors who purchased Gildan securities to participate in the investigation.

Block & Leviton is investigating Gildan Activewear Inc. for potential securities law violations following a Jehoshaphat Research report alleging channel stuffing and inflated revenue growth. Gildan's stock fell over 20% on June 16, 2026, after the report claimed approximately $500 million in excess product inventory and negative organic growth masked by aggressive sales practices.

The article compares FIGS, a specialized healthcare apparel company with premium pricing and high growth, against Gildan Activewear, a large-scale basic apparel manufacturer with lower valuations and steady cash flow. FIGS offers growth potential but faces supply chain concentration risks and premium valuation, while Gildan provides stability, dividend income, and diversified operations but with lower growth prospects. The author recommends Gildan for a steadier long-term investment path.

Barington Companies Management initiated a new position in Americold Realty Trust, purchasing 300,000 shares worth $3.86 million in Q4 2025, despite the stock declining 38.7% over the past year. The investment represents 2.53% of the fund's assets, suggesting confidence that operational improvements and better occupancy could stabilize earnings and reflect cyclical pessimism rather than structural weakness.

UBS analyst Jay Sole raised Gildan Activewear's price target by 38% to $110, citing the recent Hanesbrands acquisition as a strategic move that could improve retail presence and potentially reduce company debt.

Ararat Capital Management reduced its stake in Activewear by selling 137,548 shares in Q3, decreasing its position value by $4.9 million while maintaining Gildan as its fifth-largest holding after the HanesBrands acquisition.